Belluscura Plc

LSE:BELL UK Medical Devices
Market Cap
$36.62K
GBX300.98 Million GBX
Market Cap Rank
#49202 Global
#1317 in UK
Share Price
GBX0.75
Change (1 day)
+0.00%
52-Week Range
GBX0.55 - GBX1.65
All Time High
GBX146.50
About

Belluscura plc develops and commercialize oxygen related medical device products in the United States. The company offers X-PLOR and DISCOV-R, a modular portable oxygen concentrator; and related accessories. Belluscura plc was incorporated in 2015 and is based in London, the United Kingdom.

Belluscura Plc (BELL) - Total Liabilities

Latest total liabilities as of June 2024: GBX2.93 Million GBX

Based on the latest financial reports, Belluscura Plc (BELL) has total liabilities worth GBX2.93 Million GBX as of June 2024.

Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities.

Belluscura Plc - Total Liabilities Trend (2016–2023)

This chart illustrates how Belluscura Plc's total liabilities have evolved over time, based on quarterly financial data. Explore and compare other companies by total liabilities.

Belluscura Plc Competitors by Total Liabilities

The table below lists competitors of Belluscura Plc ranked by their total liabilities.

Company Country Total Liabilities
Catenai PLC
LSE:CTAI
UK GBX253.69K
Baltic I Acquisition Corp
V:BLTC-P
Canada CA$2.61K
RAMAYANA LESTARI
MU:OAIA
Germany €1.11 Trillion

Liability Composition Analysis (2016–2023)

This chart breaks down Belluscura Plc's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted.

Liquidity & Leverage Metrics

Key Metrics Explained

Metric Value Description
Current Ratio 3.25 Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio N/A More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio N/A Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity 0.16 Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets 0.14 Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how Belluscura Plc's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for Belluscura Plc (2016–2023)

The table below shows the annual total liabilities of Belluscura Plc from 2016 to 2023.

Year Total Liabilities Change
2023-12-31 GBX3.13 Million -3.52%
2022-12-31 GBX3.25 Million +143.63%
2021-12-31 GBX1.33 Million +134.50%
2020-12-31 GBX568.19K -29.12%
2019-12-31 GBX801.65K +217.17%
2018-12-31 GBX252.75K -81.42%
2017-12-31 GBX1.36 Million +229.60%
2016-11-30 GBX412.62K --